Effect of aspirin on the occurrence of PLP, IUGR and preeclampsia

Evaluating the effect of aspirin on the occurrence of PLP, IUGR and preeclampsia in pregnant women with a history of preeclampsia in a previous pregnancies in Khalije fars hospital Bandar abbas,Iran in 2016-2017

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20181218042033N1

Enrollment

Registered

2019-01-20

Start date

2017-04-21

Completion date

Unknown

Last updated

2019-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Intrauterine growth restriction. Condition 2: Preterm Labor Pain. Condition 3: Preeclampsia. IUGR Preterm labor Pre-eclampsia

Interventions

Intervention 1: Intervention group: an intervention group at the gestational age of 12 to 15 weeks treated with 80 mg of aspirin on a daily basis. Intervention 2: Control group: a control group that r

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: All pregnant women with a history of preeclampsia in previous pregnancies

Exclusion criteria

Exclusion criteria: Multiple Pregnancy Gestational Diabet History of previous PLP Polyhydraminosis History of other systemic diseases (such as hypertension), History of coagulation disorders Use of anticoagulant drugs Aspirin susceptibility

Design outcomes

Primary

Measure	Time frame
Preterm delivery, IUGR, Preeclampsia. Timepoint: After completing the research. Method of measurement: Study the case.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Afsaneh RozRokh

Bandare-abbas University of Medical Sciences

afroozrokh1988@gmail.com+98 76 3647 9830

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026